Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/1998
08/27/1998WO1998037421A1 Aβ DEPOSITION INHIBITOR SCREEN USING SYNTHETIC AMYLOID
08/27/1998WO1998037415A1 ULCERATIVE COLITIS pANCA SECRETORY VESICLE ANTIGEN AND METHODS OF USING SAME
08/27/1998WO1998037411A1 Assay for disease related conformation of a protein
08/27/1998WO1998037232A2 Method for determining a nucleic acid
08/27/1998WO1998037224A1 Transgenically produced non-secreted proteins
08/27/1998WO1998037222A1 Method for reversible immobilizing oligo- and/or polysaccharides
08/27/1998WO1998037217A1 A soluble vaccinia virus protein that binds chemokines
08/27/1998WO1998037215A1 IMPROVED ASSAYS FOR β-AMYLOID PROCESSING
08/27/1998WO1998037210A1 Immunological detection of prions
08/27/1998WO1998037208A1 Expression of heterologous proteins
08/27/1998WO1998037202A1 Isolation of ribosome recycling factor genes and determination of the primary structures of ribosome recycling factor genes of pseudomanas aeruginosa and one other
08/27/1998WO1998037201A1 Control of floral induction in plants and uses therefor
08/27/1998WO1998037199A1 Novel human mlf3 protein
08/27/1998WO1998037198A1 Human sodium-dependent phosphate cotransporter
08/27/1998WO1998037197A1 Novel microtubule-associated protein
08/27/1998WO1998037196A1 PARG, A GTPase ACTIVATING PROTEIN WHICH INTERACTS WITH PTPL1
08/27/1998WO1998037195A1 Morphogenic proteins
08/27/1998WO1998037194A1 Ell2, a member of an ell family of rna polymerase ii elongation factors
08/27/1998WO1998037193A1 Zcytor7 cytokine receptor
08/27/1998WO1998037192A1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes
08/27/1998WO1998037191A1 Human circulating hnlp (human neutrophil lymphocyte peptide)
08/27/1998WO1998037190A1 Method for induction of apoptotic cell death in malignant cells, through reduction of the rb to apoptosis inducing proteins ratio
08/27/1998WO1998037189A1 Ires sequences with high translational efficiency and expression vectors containing the sequence
08/27/1998WO1998037187A1 Cancer-associated genes
08/27/1998WO1998037186A1 In vitro peptide or protein expression library
08/27/1998WO1998037185A2 Vectors for controlled gene expression
08/27/1998WO1998037184A1 Leafy cotyledon1 genes and their uses
08/27/1998WO1998037180A2 Hcv fusion protease and polynucleotide encoding same
08/27/1998WO1998037178A1 Immunomodulatory polypeptides derived from the invariant chain of mhc class ii
08/27/1998WO1998037100A2 Therapeutic use of the smr1 protein and active derivatives thereof
08/27/1998WO1998037098A1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications
08/27/1998WO1998037097A1 Msh-receptor subtype selective cyclic peptides
08/27/1998WO1998037096A1 Zonula occludens toxin receptors
08/27/1998WO1998037095A2 Recombinant pox virus for immunization against muc1 tumor-associated antigen
08/27/1998WO1998037094A2 Secreted proteins and polynucleotides encoding them
08/27/1998WO1998037093A2 Compounds for immunotherapy of prostate cancer and methods for their use
08/27/1998WO1998037091A2 Modified retinoblastoma tumor suppressor proteins
08/27/1998WO1998037090A1 Antipathogenic synthetic peptides and compositions comprising them
08/27/1998WO1998037089A2 Matrix derived anti-hiv peptides and transdominant proteins
08/27/1998WO1998037086A1 Method for removing viruses from protein solution by nanofiltration
08/27/1998WO1998037085A1 Netrin receptors
08/27/1998WO1998037053A1 Identification of a unique receptor specific for a particular retinoid inducing cellular apoptosis
08/27/1998WO1998036779A2 System for the in vivo delivery and expression of heterologous genes in the bone marrow
08/27/1998WO1998036771A1 Method for the production of vaccines against cell surface proteins
08/27/1998WO1998036767A1 Modulation of the hypothalamic-pituitary-adrenal-adipose axis with leptin receptor ligands
08/27/1998WO1998036766A1 Anti-hiv protein
08/27/1998WO1998036765A1 Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18
08/27/1998WO1998036641A1 Control of il4 production as a therapeutic regulator of immune function
08/27/1998WO1998028419A3 Methods and compositions for modulation of vesicular release
08/27/1998WO1998022503A3 Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide, a combinatorial antigen, and a method of detecting auto-immune antibodies
08/27/1998WO1998022441A3 N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and methods for inhibiting beta-amyloid peptide and/or its synthesis
08/27/1998WO1998022140A3 Hybrid compositions for intracellular targeting
08/27/1998WO1998021231A3 Streptococcus uberis lactoferrin-binding protein
08/27/1998WO1998017827A3 Compositions and methods using eukaryotic rad52
08/27/1998WO1998017814A3 Gene expression and delivery systems and uses
08/27/1998WO1998013499A3 Packaging cell lines for use in facilitating the development of high-capacity adenoviral vectors
08/27/1998WO1998007844A3 Screening assay for the identification of agents which alter expression of pth-rp
08/27/1998WO1998007748A3 Plag gene family and tumorigenesis
08/27/1998WO1998006437A3 Compositions and methods for polynucleotide delivery
08/27/1998DE19707508A1 Preparation of pure, stable haemoglobin
08/27/1998CA2742641A1 Compounds for immunotherapy of prostate cancer and methods for their use
08/27/1998CA2283090A1 Method for induction of apoptotic cell death in malignant cells, through reduction of the rb to apoptosis inducing proteins ratio
08/27/1998CA2282859A1 Method for the production of vaccines against cell surface proteins
08/27/1998CA2282504A1 Isolation and structural elucidation of the cytostatic linear and cyclo-depsipeptides dolastatin 16, dolastatin 17, and dolastatin 18
08/27/1998CA2282341A1 Modulation of the hypothalamic-pituitary-adrenal-adipose axis with leptin receptor ligands
08/27/1998CA2282302A1 Morphogenic proteins
08/27/1998CA2281949A1 Transgenically produced non-secreted proteins
08/27/1998CA2281912A1 Therapeutic use of the smr1 protein and active derivatives thereof
08/27/1998CA2281899A1 Modified retinoblastoma tumor suppressor proteins
08/27/1998CA2281897A1 Control of floral induction in plants and uses therefor
08/27/1998CA2281674A1 Parg, a gtpase activating protein which interacts with ptpl1
08/27/1998CA2281669A1 Human sodium-dependent phosphate cotransporter
08/27/1998CA2281617A1 Zonula occludens toxin receptors
08/27/1998CA2281523A1 Identification of a unique receptor specific for a particular retinoid inducing cellular apoptosis
08/27/1998CA2281487A1 Leafy cotyledon1 genes and their uses
08/27/1998CA2281204A1 Antipathogenic synthetic peptides and compositions comprising them
08/27/1998CA2281059A1 Secreted proteins and polynucleotides encoding them
08/27/1998CA2278577A1 Assay for disease related conformation of a protein
08/27/1998CA2251645A1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications
08/26/1998EP0860504A1 Polypeptides of feline T-cell lymphotropic lentivirus
08/26/1998EP0860502A1 cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor
08/26/1998EP0860501A2 Corticotropin-releasing factor2 receptors
08/26/1998EP0860447A1 Hematopoietic stem cell growth factor (scgf)
08/26/1998EP0860446A1 Type cc chemokine-like protein
08/26/1998EP0860445A1 New nucleotide sequences for the cell cycle regulated expression of structural genes
08/26/1998EP0860444A1 Method for removing viruses from a protein solution
08/26/1998EP0860442A1 Oligosaccharide oxazolines, oligosaccharide conjugates and methods of preparation thereof
08/26/1998EP0859959A1 Peptides which enhance transport across tissues and methods of identifying and using the same
08/26/1998EP0859860A1 Diagnosis of susceptibility to cancer and treatment thereof
08/26/1998EP0859855A1 In vitro construction of sv40 viruses and pseudoviruses
08/26/1998EP0859854A1 Retroviral vectors carrying senescent cell derived inhibitors 1 (sdi-1) or antisense sdi-1 nucleotide sequences
08/26/1998EP0859852A1 Commercial production of aprotinin in plants
08/26/1998EP0859851A1 Juvenile hormone or one of its agonists as a chemical ligand to control gene expression in plants by receptor mediated transactivation
08/26/1998EP0859849A1 NOVEL POLYPEPTIDES AND POLYNUCLEOTIDES RELATING TO THE $g(a)- and $g(b)-SUBUNITS OF GLUTAMATE DEHYDROGENASES AND METHODS OF USE
08/26/1998EP0859847A1 Composition and method of imparting resistivity to hiv superinfection to cells
08/26/1998EP0859846A1 Rabies recombinant adenovirus
08/26/1998EP0859845A1 Novel cell surface protein compounds
08/26/1998EP0859844A1 Interleuken-3 (il-3) receptor agonists
08/26/1998EP0859843A1 Novel g-csf receptor agonists
08/26/1998EP0859842A1 SHORT FORMS OF CHEMOKINE $g(b)-8
1 ... 2364 2365 2366 2367 2368 2369 2370 2371 2372 2373 2374 2375 2376 2377 2378 2379 2380 2381 2382 2383 2384 ... 2916